Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 16, 2026

Phospho Flow Cytometry with Fluorescent Cell Barcoding for Single Cell Signaling Analysis and Biomarker Discovery
08:38

Phospho Flow Cytometry with Fluorescent Cell Barcoding for Single Cell Signaling Analysis and Biomarker Discovery

Published on: October 4, 2018

Reply: To PMID 22421118

Sara G A van Velsen, Inge M Haeck, Carla A F M Bruijnzeel-Koomen

    Journal of the American Academy of Dermatology
    |December 19, 2012
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Last Updated: May 16, 2026

    Phospho Flow Cytometry with Fluorescent Cell Barcoding for Single Cell Signaling Analysis and Biomarker Discovery
    08:38

    Phospho Flow Cytometry with Fluorescent Cell Barcoding for Single Cell Signaling Analysis and Biomarker Discovery

    Published on: October 4, 2018

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Dupilumab versus tralokinumab in atopic dermatitis: A propensity score adjusted comparison from BioDay.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2026
    Same author

    Addressing potential bias when assessing safety of biologics and JAK inhibitors in atopic dermatitis.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2026
    Same author

    Current treatment landscape of atopic dermatitis focusing on real-world evidence of dupilumab treatment.

    Expert opinion on biological therapy·2025
    Same author

    Topical Steroid Withdrawal: Perspectives of Dutch Healthcare Professionals.

    Acta dermato-venereologica·2025
    Same author

    Real-world Cost per Responder Among Different Classes of Biologics for the Treatment of Psoriasis.

    Acta dermato-venereologica·2025
    Same author

    Lower Drug Survival, Less Satisfaction and More Adverse Events in Females Using Biologics for Psoriasis: Results of the Dutch BioCAPTURE Registry.

    Journal of psoriasis and psoriatic arthritis·2025
    Same journal

    Sexual function is missing from the adverse-effect map of GLP-1 receptor agonists in dermatology.

    Journal of the American Academy of Dermatology·2026
    Same journal

    Comparative risk of reactivation of hepatitis B and C after treatment with biologics and targeted synthetic DMARDs in psoriasis and psoriatic arthritis: a 15-year multicenter cohort study.

    Journal of the American Academy of Dermatology·2026
    Same journal

    Safety of Biologic Therapy in Psoriasis Patients With Malignancy.

    Journal of the American Academy of Dermatology·2026
    Same journal

    Letter from the Editor: Glucagon-Like Peptide-1 (GLP-1) agonists in dermatology.

    Journal of the American Academy of Dermatology·2026
    Same journal

    Rethinking the Occipital Scalp as a Control in Advanced Androgenetic Alopecia.

    Journal of the American Academy of Dermatology·2026
    Same journal

    Parallel-Polarized Dermoscopy for Acral Parallel Pattern Analysis.

    Journal of the American Academy of Dermatology·2026
    See all related articles